Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above __?
Resolved5as of
This hub tracks 5 outcomes of this event, with the news signals that move them.
What are the odds right now?
Each outcome shows its current market price — the market-implied probability it happens. Click an outcome for its full market page.
What moved the odds?
12 AI-matched news signals available across this event, newest first. Entry price is the called side when the news hit; the signed return marks it against the outcome’s final price as of .
$JNJ Johnson & Johnson Q2 2026 Earnings • -Adj EPS $2.90 (est $2.85) • -Sales $25.31B (est 25.04B) • -Medtech Sales $8.93b (est $8.99b) • -Medicine Revenue $16.38b (est $16.12b) • -Sees FY Sales $100.88 To $101.48, Saw $100.3b To $101.3b • -Sees FY Adj EPS $11.60 To $11.75, Saw $11.45 To $11.65 • Sees FY Sales $100.8b To $101.4b, Saw $100.3b To $101.3b
*JOHNSON & JOHNSON 2Q SALES $25.31B, EST. $25.04B
*JOHNSON & JOHNSON 2Q SALES $25.31B, EST. $25.04B
*JOHNSON & JOHNSON 2Q SALES $25.31B, EST. $25.04B
*JOHNSON & JOHNSON 2Q SALES $25.31B, EST. $25.04B
*JOHNSON & JOHNSON 2Q SALES $25.31B, EST. $25.04B
RPT-BUZZ-PREVIEW: Johnson & Johnson seen reporting strong quarterly revenue growth
RPT-BUZZ-PREVIEW: Johnson & Johnson seen reporting strong quarterly revenue growth
RPT-BUZZ-PREVIEW: Johnson & Johnson seen reporting strong quarterly revenue growth
RPT-BUZZ-PREVIEW: Johnson & Johnson seen reporting strong quarterly revenue growth
What is this event about?
This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming second fiscal quarter, as reported in its official company earnings materials, is above the listed amount. Otherwise, this market will resolve to "No".
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is Johnson & Johnson's official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.